Balchem Corporation (FRA:BL9B)

Market Cap	4.46B
Revenue (ttm)	863.85M
Net Income (ttm)	127.17M
Shares Out	n/a
EPS (ttm)	3.89
PE Ratio	35.09
Forward PE	29.11
Dividend	0.82 (0.63%)
Ex-Dividend Date	Dec 23, 2025

Volume	n/a
Average Volume	2
Open	128.60
Previous Close	134.50
Day's Range	128.60 - 128.60
52-Week Range	118.60 - 167.20
Beta	n/a
RSI	60.28
Earnings Date	Feb 20, 2026

About Balchem

Balchem Corporation develops, manufactures, and markets specialty performance ingredients and products for the nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition, and industrial markets worldwide. It operates through three segments: Human Nutrition and Health, Animal Nutrition and Health, and Specialty Products. The Human Nutrition & Health segment supplies ingredients in the food and beverage industry. Its products include spray dried and emulsified powders, extrusion and agglomeration, blended lipi...

• Industry: Industrial Organic Chemicals
• Founded: 1967
• Employees: 1,361
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: BL9B

Financial Performance

In 2024, Balchem's revenue was $953.68 million, an increase of 3.39% compared to the previous year's $922.44 million. Earnings were $128.48 million, an increase of 18.36%.

Financial numbers in USD